Oral Side Effects in Patients with Metastatic Renal Cell Carcinoma Receiving the Antiangiogenic Agent Pazopanib—Report of Three Cases
Erofili Papadopoulou(National and Kapodistrian University of Athens), Nikolaos G. Nikitakis(United Hospital), Maria Georgaki(National and Kapodistrian University of Athens), Evangelia Piperi(National and Kapodistrian University of Athens), Emmanouil Vardas(National and Kapodistrian University of Athens), Styliani Tziveleka(KAT General Hospital of Attica), Konstantinos Katoumas(National and Kapodistrian University of Athens), Maria Kouri(National and Kapodistrian University of Athens)
Cited by 9
Related Papers
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma
|Molecular Cancer|2007|275
Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck
|Cancer Research|2005|243
Ameloblastoma in children
|Journal of Oral and Maxillofacial Surgery|2002|161
Clinicopathologic characterization of oral angioleiomyomas
|Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology|2002|139
Primary intraosseous odontogenic carcinoma arising in an odontogenic cyst or de novo: A clinicopathologic study of six new cases
|Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology|2005|125